Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion type Assertion NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_head.
- NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion description "[P-cadherin was present in 80 of the 261 breast cancers (31%) and was more frequently present in tumors that have a basal epithelial phenotype [i.e., high-grade, estrogen receptor- and KIP1 (p27(Kip1))-negative tumors, with expression of cytokeratin 5/6, cyclin E, TP53, and presence of BRCA1 mutations and vascular nests (all P < 0.001)].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_provenance.
- NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion evidence source_evidence_literature NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_provenance.
- NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion SIO_000772 15930334 NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_provenance.
- NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion wasDerivedFrom befree-20140225 NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_provenance.
- NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_assertion wasGeneratedBy ECO_0000203 NP475729.RADZP6A6fh8r_Vo_rmH5CAhwzerBBAaM3lx1zwCMmAEEE130_provenance.